This Solicitation opportunity from Government of Canada was posted on January 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Endosafe MCS Endotoxin/Limulus Amebocyte Lysate (LAL) Reagents and Cartridges

Closed

BCPHSA_11331International

Submission Closed01/18/2026, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, CORONAVIRUS DThe contract is for the procurement of COVID-19 test kits under NSN 6550-01-716-1573, with a requested quantity of three units. The solicitation, identified by number SPE2DS-26-T-269U, was posted on July 26, 2026, and responses are due by August 3, 2026. This is a federal solicitation issued by the Defense Logistics Agency on behalf of the Department of Defense, with no specific set-aside classification applied. The place of performance and office address details are not specified, though the contracting activity is based in the United States. Interested parties can access the solicitation through the DIBBS system using the provided UI link.

Defense Logistics Agency

POSTED

DEADLINE

TEST KIT, HUMAN IMMUNODThe contract is for the procurement of a TEST KIT, HUMAN IMMUNOD with NSN/Part Number 6550-01-692-1809, under Purchase Request 7017623218 for a quantity of seven units. The solicitation is issued by the Defense Logistics Agency on behalf of the Department of Defense under solicitation number SPE2DS-26-T-269L, with the posting date listed as July 26, 2026, and responses due by August 3, 2026. The contract is classified as a federal solicitation with no set-aside designation, and the place of performance and office address details are unspecified, though the contracting entity is based in the United States. The solicitation is accessible via the DIBBS platform for interested vendors to review and submit proposals.

Defense Logistics Agency

POSTED

DEADLINE

PHENOL RED PH TEST TABThe contract pertains to the procurement of PHENOL RED PH TEST TAB with the NSN 6550-01-095-6757, issued under solicitation number SPE2DS-26-T-269R by the Defense Logistics Agency on behalf of the Department of Defense. The request seeks a quantity of two units, with the solicitation posted on July 26, 2026, and responses due by August 3, 2026. This is a federal procurement action with no specific set-aside designation, and the performance location and contact details are not provided. The offeror must respond through the DIBBS portal linked in the solicitation, and the item is intended for use in pH testing applications within a federal operational context.

Defense Logistics Agency

POSTED

DEADLINE

BACTERIOLOGICAL SPECIMThe Defense Logistics Agency under the Department of Defense has issued a solicitation for bacteriological specimens identified by NSN 6550-01-474-0651, with a requested quantity of two units. The solicitation, numbered SPE2DS-26-T-271J, was posted on July 26, 2026, and responses are due by August 3, 2026. This federal procurement is intended to fulfill a specific operational need, though no set-aside classification or NAICS code is specified. The place of performance and point of contact information are not provided, and the contract is administered through the DLA’s online bidding platform accessible via the provided UI link. All submissions must comply with the solicitation requirements and be received before the stated deadline.

Defense Logistics Agency

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche Flu Surveillance Testing ReagentThe contract anticipates the procurement of testing reagents for influenza surveillance under the Forensic Sciences Division of the District of Columbia for fiscal year 2026. The initiative is part of a broader public health effort to monitor flu activity, with reagents intended for use in diagnostic and surveillance testing. While specific quantities, delivery timelines, or technical specifications are not detailed in the forecast, the reagents will support laboratory-based detection and analysis of influenza strains across the jurisdiction. This procurement is categorized as a forecast, indicating it is a planning tool for vendors to prepare for an upcoming solicitation, and no formal solicitation number has been issued as of the posting date. The agency responsible, DFS, is based in Washington D.C., and performance is expected to occur within the district, though no specific location is provided. Vendors interested in participating should monitor future official solicitations, as this forecast serves only as an early indicator of intent and does not constitute a binding request for proposals.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Cepheid Norovirus, Mpox, Multiplex ReagentThe contract pertains to the acquisition of testing supplies specifically for the Cepheid Norovirus, Mpox, and Multiplex reagents under the Fiscal Year 2026 forecast for the Department of Forensic Sciences in the District of Columbia. It is categorized as a forecast listing, indicating it is a planned procurement rather than an active solicitation, with no formal solicitation number assigned at this time. The primary focus is on reagents used in diagnostic testing to support forensic and public health laboratories, likely to enhance detection capabilities for infectious agents relevant to criminal investigations and community health monitoring. There is no designated set-aside type, NAICS code, or organizational type specified, and the agency details are limited to the Forensic Sciences division within the District of Columbia, with no明确 office address or place of performance provided. No point of contact information is listed, and the contract remains in a pre-solicitation phase, intended to inform potential vendors of upcoming procurement needs. The associated UI link provides access to the official forecast posting for further details as the procurement process advances.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Qiagen reagentsThe contract forecasts the procurement of Qiagen reagents for forensic science testing applications under the Fiscal Year 2026 budget cycle, managed by the Forensic Sciences division within the District of Columbia. This initiative is tied to laboratory operations requiring reliable molecular diagnostics reagents, likely supporting DNA analysis, sample preparation, or other forensic testing workflows essential to criminal investigations and evidence processing. While the solicitation number and procurement details are not yet available, the posting date indicates this is a future forecast with no set-aside provisions indicated, meaning the opportunity is open to all eligible vendors without geographic or size-based restrictions. The place of performance and organizational details remain unspecified, but the activity is centered within the District of Columbia’s forensic system, suggesting delivery and use will occur at state or local forensic laboratories. No point of contact information is provided at this stage, and the NAICS code, office address, and other typical contracting metadata are also absent, indicating this is an early-stage forecast meant for market research and vendor awareness. Interested suppliers should monitor the official DC contracting portal for future solicitations tied to this forecast, as detailed requirements, timelines, and ordering procedures will be released in subsequent procurement actions.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - IDT Sequencing ReagentThe contract forecast pertains to the procurement of sequencing reagents for the Forensic Sciences Division of the District of Columbia, scheduled for fiscal year 2026. The solicitation is intended to support forensic DNA analysis operations, with the reagents critical to maintaining the accuracy and efficiency of sequencing workflows used in criminal investigations and evidence processing. Despite the lack of specific solicitation numbers, NAICS codes, or set-aside details, the anticipated procurement reflects an ongoing operational need within the agency’s forensic laboratory capabilities. The place of performance and point of contact information are currently unspecified, suggesting the details are still under development or will be finalized closer to the formal solicitation release. The posting date indicates the forecast is publicly available to potential vendors as an early notification ahead of a future bid opportunity, allowing suppliers to prepare proposals and align their offerings with the agency’s requirements.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Illumina AMD reagentsThe District of Columbia’s Forensic Sciences Division is forecasting procurement needs for AMD testing reagents in fiscal year 2026, with the solicitation posted on July 23, 2026. This forecast indicates an upcoming requirement for reagents used in forensic DNA analysis, likely supporting laboratory operations for criminal investigations and evidence processing. The contract is intended for Illumina-branded AMD reagents, suggesting a specific technology platform is preferred for genotyping or sequencing applications in the forensic context. Although the solicitation number, NAICS code, set-aside details, and office location are not yet specified, the procurement is being managed under the agency’s procurement portal and will likely proceed through a formal competitive process. Performance is expected to be delivered within the District of Columbia, aligning with the agency’s operational base. Interested vendors should monitor the official contract portal for the eventual release of a formal request for proposal, as this forecast serves as a preliminary notice to prepare for potential bidding opportunities.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Other Microbiology Testing ReagentsThe contract pertains to the procurement of microbiology testing reagents for the Forensic Sciences division of the District of Columbia, scheduled for fiscal year 2026. It is posted as a forecast with no solicitation number yet assigned, indicating it is a planning notice rather than an active bid opportunity. The reagents are intended to support forensic microbiology analyses, likely for use in criminal investigations, public health investigations, or other forensic science applications requiring precise microbial identification and analysis. There is no information provided on set-aside status, NAICS code, or specific organizational type, and the place of performance and point of contact details are incomplete or unlisted. The forecast was published on July 23, 2026, and is accessible via the District of Columbia’s contracts portal, suggesting that interested vendors should monitor for a formal solicitation in the near future.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche testing reagentsThe contract pertains to the procurement of Roche testing reagents for the Fiscal Year 2026 forecasting period under the Forensic Sciences Division of the District of Columbia. It is classified as a forecast notice, indicating a planned future procurement rather than an active solicitation, with no specific solicitation number assigned at this time. The reagents are intended for use in forensic laboratory testing and are likely required to support ongoing or anticipated casework involving DNA analysis, toxicology, or other forensic diagnostic applications. The agency responsible is the District of Columbia’s Forensic Sciences office, with no set-aside designation or NAICS code listed, suggesting the procurement may be open to general competition without specific small business or other socioeconomic preferences. The place of performance and point of contact information are not provided, and the only available link directs to the District’s contracts portal for further details. This forecast serves as early notice to potential suppliers to prepare for an upcoming solicitation.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Varies LRN-C Testing ReagentsThe contract focuses on the procurement of LRN-C testing reagents for fiscal year 2026 under the Forensic Sciences division of the District of Columbia, aimed at supporting laboratory testing capabilities. While specific reagent types and quantities are not detailed, the solicitation is classified as a forecast indicating future intent to procure, with no formal solicitation number yet assigned. The funding and requirements are tied to the Department of Public Health's forensic objectives, likely to ensure readiness for public health emergencies or forensic investigations requiring certified laboratory analysis. No set-aside provisions, NAICS codes, or point of contact information are provided at this stage, and the place of performance remains unspecified, though the agency location implies delivery within the District of Columbia. This forecast allows vendors to prepare for potential future bidding opportunities, with the official solicitation expected to follow after further planning and budget allocation.

Forensic Sciences (DFS)

POSTED

3 days ago

DEADLINE

N/A

AI Contract Overview

The Provincial Health Services Authority (PHSA) plans to directly award a five-year contract to Charles River Microbial Solutions International Ltd., located in Wilmington, Massachusetts, to supply Endosafe MCS Endotoxin/Limulus Amebocyte Lysate (LAL) Reagents and Cartridges for the BC Centre for Disease Control. This procurement is identified under solicitation number BCPHSA_11331 and was posted on January 8, 2026, with a response deadline of January 18, 2026. The contract supports the ongoing need for specialized reagents and cartridges essential for endotoxin testing, which is critical for ensuring the safety and quality of medical products within the healthcare system. The contract is managed by PHSA, a federal organization under the Government of Canada, and the primary point of contact for this award is Rizette Cubias, the contracting authority. While the contract specifics, such as the place of performance, are not detailed, the arrangement emphasizes a direct award process, indicating a non-competitive procurement due to the specialized nature of the goods or a preferred supplier relationship. This initiative ensures the BC Centre for Disease Control maintains a reliable supply of these critical testing materials over the contracted term.

General Info

PHSA awards five-year direct contract to Charles River for endotoxin testing reagents and cartridges.

Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)View Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJan 8

Solicitation

Response DeadlineJan 18

Deadline has passed

Submission Closed

01/18/2026, 10:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Provincial Health Services Authority (Incl. BCCSS)

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)

View Agency Profile

Office AddressN/A

Contacts

Rizette CubiasContracting Authority

contact@example.gov

Full Description

Notice is hereby given that Provincial Health Services Authority (“PHSA”), intends to directly award a Contract to the following supplier to provide Endosafe MCS Endotoxin/Limulus Amebocyte Lysate (LAL) Reagents and Cartridges for BC Centre for Disease Control for a term of five (5) years. Charles River Microbial Solutions International Ltd.251 Ballardvale St.,Wilmington, MA,USA 01887